Using specific inhibitors of the PI3K/AKT pathway can significantly reduce the expression of antiapoptosis protein Bcl-xl and induce caspase-3- (caspase-3-) dependent apoptosis, thus inhibiting cell proliferation and tumor growth in vivo [83]. The gene discussed is PIK3CA; the disease is neoplasm.